Non-Muscle-invasive Bladder Cancer (NMIBC) Not Yet Recruiting Phase 4 Trials for Hexaminolevulinate (DB06261)

Back to Non-Muscle-invasive Bladder Cancer (NMIBC)

Also known as: Non-Muscle- Invasive Bladder Cancer / NMIBC / Non-muscle Invasive Bladder Cancer / Non Muscle-invasive Bladder Cancer / Non-muscle-invasive Bladder Cancer / Non-muscle Invasive Bladder Cancer (NMIBC) / Non Muscle Invasive Bladder Cancer / Nonmuscle Invasive Bladder Cancer / Non-Muscle Invasive Bladder Neoplasms / Carcinoma of urinary bladder, superficial (disorder) / Urothelial carcinoma bladder / Bladder transitional cell carcinoma / Transitional cell carcinoma of bladder (disorder)

Indication	Status	Phase
DBCOND0082324 (Non-Muscle-invasive Bladder Cancer (NMIBC))	Not Yet Recruiting	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05962541	Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs)	Treatment	Hexaminolevulinate (DB06261)